Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies.
Martin Alan MenterJennifer C CatherMichael JarrattXiangyi MengAdriana GuanaJudit NyiradyPublished in: Dermatology and therapy (2016)
ClinicalTrials.gov identifiers: NCT01365455, NCT01358578, NCT01555125, and NCT01636687.